CTRI/2021/12/038732尚未招募未知
Effect of Tofacitinib added to standard therapy on ICU stay in critically ill patients with COVID 19 infection - A prospective randomized control study
Bangalore Medical College and Research Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. SARS Co V2 positivity to the nasal swab by RTPCR
- •2. Presence of radiological findings of pneumonia assessed by chest radiography and HRCT
- •3. Patients with eGFR 15-30 ml/min
- •4. PaO2/ FiO2 100-300 mmHg at ABG
排除标准
- •1. Patients with active / latent tuberculosis
- •2. Patients with pre - existing AKI, EGFR < 15ml/min
- •3. Patients with deranged liver function test
- •4. Patients with history of chronic dialysis and renal transplant
- •5. Patients with history of thrombophlebitis and acute / chronic autoimmune disorder
- •6. Patients with serology positive
- •7. Patients on immunosuppressive drugs
- •8. Pregnant and lactation
研究者
相似试验
招募中
2 期
Effect of tofacitinib in COVID-19virus identifiedCondition 1: COVID-19. Condition 2: COVID-19.virus not identifiedClinically-epidemiologically diagnosed COVID-19Probable COVID-19Suspected COVID-19U07.1U07.2IRCT20200329046892N2Rasht University of Medical Sciences60
招募中
1 期
Effects of Tofacitinib on Ulcerative Colitis patientslcerative Colitis.Ulcerative colitisIRCT20181217042020N2Digestive Disease Research Institute of Tehran University of Medical Sciences40
进行中（未招募）
1 期
Effect of Tofacitinib on inflammation following pancreas transplantatioIschaemia reperfusion injury and allograft pancreatitis.MedDRA version: 20.1 Level: PT Classification code 10066127 Term: Ischaemic pancreatitis System Organ Class: 10017947 - Gastrointestinal disordersEUCTR2017-002784-18-GBClinical Trials and Research Governance20
已完成
4 期
effectiveness of tofacitinib in moderate to severe ulcerative colitis compared to steroidCTRI/2023/09/057448Shankar Roy94
尚未招募
4 期
sefulness of tofacitinib in atopic dermatitisCTRI/2024/08/072026AIIMS Bhubaneswar